openPR Logo
Press release

Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Diseases to Boost Global Demand for IVIG Products

05-09-2017 04:19 PM CET | Health & Medicine

Press release from: Transparency Market Research

Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence

This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails.

Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global intravenous immunoglobulin (IVIG) market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

Browse Market Research Report @ http://www.transparencymarketresearch.com/intravenous-immunoglobulin-market.html

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also provide insights into the key trends of the intravenous immunoglobulin (IVIG) market such as shift from intravenous to subcutaneous infusion of immunoglobulin.

The key market indicators influencing global intravenous immunoglobulin (IVIG) market taken into consideration include prevalence of immunological disorders, global blood and plasma yield and geriatric population. The report also includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global intravenous immunoglobulin (IVIG) market. The report also highlights key events of the global intravenous immunoglobulin industry. A value chain analysis along with list of major players, hospitals and distributors is also included in the report.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. The year on year growth of global intravenous immunoglobulin (IVIG) market for each segment is also reflected. Additionally, market related factors such as increasing preference for product innovation, and growing number of acute and chronic patients in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Based on indication, the global intravenous immunoglobulin (IVIG) market has been segmented into chronic inflammatory demyelinating polyneuropathy (CIDP), primary humoral immunodeficiency, idiopathic thrombocytopenic purpura (ITP), Guillain-Barre syndrome, myasthenia gravis, multifocal motor neuropathy (MMN), Kawasaki disease, hypogammaglobulinemia, chronic lymphocytic leukemia, and others. Based on end-user, the market has been segmented into hospitals, clinics, and home care. Hospitals segment is expected to remain dominant during the forecast period. However, home care segment is expected to grow at a higher CAGR than others.

For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1930

Geographically, the global intravenous immunoglobulin (IVIG) market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented into major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia, India, Japan, Brazil, and Mexico.

The report also profiles major players in the intravenous immunoglobulin (IVIG) market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. A thorough market share analysis of major companies operating in the intravenous immunoglobulin (IVIG) market is provided in the report.

The report also includes a competition matrix that provides insights into recent developments and activities done by the major market players. Key companies profiled in the report include Baxalta Incorporated, Biotest AG, China Biologic Products, Inc., CSL Behring LLC, Grifols S.A., Kedrion S.p.A., LFB Biomedicaments S.A., Octapharma AG, and Sanquin Plasma Products B.V.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Diseases to Boost Global Demand for IVIG Products here

News-ID: 529674 • Views:

More Releases from Transparency Market Research

Oxidative Stress Assays Market to Reach US$ 2.8 Bn by 2034 Driven by Advancements in Biopharmaceutical Research and ROS Biomarker Analysis: Transparency Market Research
Oxidative Stress Assays Market to Reach US$ 2.8 Bn by 2034 Driven by Advancement …
The global oxidative stress assays market stood at US$ 1.0 Bn in 2023. It is projected to grow at a CAGR of 9.4% from 2024 to 2034 and is estimated to reach US$ 2.8 Bn by the end of 2034, according to a latest market study by Transparency Market Research. Analyst Viewpoint Rising demand for biomarker-based testing in the biopharmaceutical and biotechnology industries is significantly propelling the oxidative stress assays market growth.
Oxycodone Hydrochloride Market to Reach US$ 675.2 Mn by 2034 amid Rising Surgical Volume and Chronic Disease Burden: Transparency Market Research
Oxycodone Hydrochloride Market to Reach US$ 675.2 Mn by 2034 amid Rising Surgica …
The global oxycodone hydrochloride market stood at US$ 403.9 Mn in 2023. The market is anticipated to grow at a CAGR of 4.8% from 2024 to 2034 and reach US$ 675.2 Mn by the end of 2034, according to the latest research report by Transparency Market Research. Rising number of surgical interventions globally, increasing need for pain management in chronic ailments, and greater awareness of opioid therapeutics are key factors driving
Viral Vectors for Non-human Primates Market to Reach Over US$ 429.9 Mn by 2034, Driven by Expanding Gene Therapy Pipelines and Advanced Therapeutic Applications: Transparency Market Research
Viral Vectors for Non-human Primates Market to Reach Over US$ 429.9 Mn by 2034, …
The global viral vectors for non-human primates market was valued at US$ 145.8 Mn in 2023 and is projected to grow at a CAGR of 10.5% from 2024 to 2034, reaching over US$ 429.9 Mn by the end of 2034, according to a recent report by Transparency Market Research. Analyst Viewpoint Viral vectors play a pivotal role in advancing gene therapy, vaccine development, and regenerative medicine by enabling precise gene delivery into
Phytoestrogen Supplements Market to Reach USD 6.3 Billion by 2034 Amid Soaring Demand for Plant-Based Wellness Solutions | Transparency Market Research
Phytoestrogen Supplements Market to Reach USD 6.3 Billion by 2034 Amid Soaring D …
The global Phytoestrogen Supplements Market is poised for substantial growth in the coming decade. Valued at US$ 3.8 billion in 2023, the market is forecast to expand at a steady CAGR of 4.7% from 2024 to 2034, reaching an estimated US$ 6.3 billion by 2034. This promising outlook is driven by a rising global focus on plant-based dietary and cosmetic solutions, alongside growing awareness of women's health, particularly during the

All 5 Releases


More Releases for IVIG

Intravenous Immunoglobulin (IVIG) Market Size Worth USD 24.76 Billion in 2032 | …
The global Intravenous Immunoglobulin (IVIG) market size was USD 12.10 Billion in 2022 and is expected to register a revenue CAGR of 7.5% during the forecast period. The global intravenous immunoglobulin market is witnessing robust growth, driven by several key factors such as the increasing prevalence of immunodeficiency diseases, rising adoption of Intravenous Immunoglobulin (IVIG) treatment, and rapid technological advancements in therapy. Click To get SAMPLE PDF (Including Full TOC, Graphs
Global Intravenous Immunoglobulin (IVIg) Market Research Report 2023-2029
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or "lot" of Intravenous Immunoglobulin. Intravenous Immunoglobulin (IVIg) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Intravenous Immunoglobulin (IVIg) market is projected to reach US$ 15470
Intravenous Immunoglobulin (IVIG) Market 2023 Size, Share, Industry, Forecast to …
The Intravenous Immunoglobulin (IVIG) Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Intravenous Immunoglobulin (IVIG) market. This report explores all the key factors affecting the growth of the global Intravenous Immunoglobulin
Intravenous Immunoglobulin (IVIg) Market: Worldwide Demand, Growth Potential & O …
Intravenous Immunoglobulin (IVIg) Market 2022 The term "immunoglobulin" refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia,
IVIg Powder Market 2022-2028 Global Key Manufacturers' Analysis Review
The "Global IVIg Powder Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the IVIg Powder market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading IVIg Powder market players and offers key trends
Intravenous Immunoglobulin (IVIg) Market to Move through Glossy Innovation by 20 …
(United States, Portland ): Big Market Research newly added a research report on the Intravenous Immunoglobulin (IVIg) Market which represents a study for the period from 2021 to 2026. The research study provides a near look at the market scenario and dynamics impacting its growth. This report highlights the crucial developments along with other events happening in the market which are marking on the growth and opening doors for future growth